| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 56 | 2023 | 1286 | 1.970 |
Why?
|
| Aldosterone | 14 | 2022 | 60 | 1.010 |
Why?
|
| Fenofibrate | 10 | 2018 | 58 | 1.010 |
Why?
|
| Hypertrophy, Left Ventricular | 15 | 2009 | 106 | 0.770 |
Why?
|
| Calcinosis | 6 | 2010 | 172 | 0.740 |
Why?
|
| Blood Pressure | 27 | 2023 | 1329 | 0.740 |
Why?
|
| Cacao | 2 | 2010 | 5 | 0.710 |
Why?
|
| Coronary Disease | 6 | 2010 | 641 | 0.710 |
Why?
|
| Sodium Chloride, Dietary | 11 | 2023 | 38 | 0.700 |
Why?
|
| Polymorphism, Single Nucleotide | 22 | 2023 | 2604 | 0.610 |
Why?
|
| Sodium, Dietary | 9 | 2014 | 35 | 0.580 |
Why?
|
| Middle Aged | 104 | 2020 | 26384 | 0.580 |
Why?
|
| Lipoproteins, LDL | 7 | 2016 | 118 | 0.580 |
Why?
|
| Dietary Fats | 7 | 2020 | 298 | 0.570 |
Why?
|
| Triglycerides | 18 | 2016 | 567 | 0.570 |
Why?
|
| Hypolipidemic Agents | 7 | 2015 | 178 | 0.550 |
Why?
|
| Renin | 14 | 2020 | 89 | 0.530 |
Why?
|
| Insulin Resistance | 11 | 2020 | 644 | 0.510 |
Why?
|
| Renin-Angiotensin System | 8 | 2012 | 96 | 0.500 |
Why?
|
| Cholesterol, HDL | 13 | 2017 | 350 | 0.480 |
Why?
|
| Coronary Vessels | 3 | 2010 | 539 | 0.470 |
Why?
|
| Cholesterol | 10 | 2020 | 533 | 0.470 |
Why?
|
| Metabolic Syndrome | 7 | 2015 | 331 | 0.470 |
Why?
|
| Lipoproteins, VLDL | 6 | 2014 | 58 | 0.450 |
Why?
|
| Lipids | 6 | 2018 | 512 | 0.440 |
Why?
|
| Adult | 78 | 2020 | 29374 | 0.440 |
Why?
|
| Caveolin 1 | 3 | 2020 | 47 | 0.440 |
Why?
|
| Diet | 7 | 2015 | 1133 | 0.420 |
Why?
|
| Carnitine O-Palmitoyltransferase | 3 | 2020 | 25 | 0.420 |
Why?
|
| Male | 109 | 2020 | 60910 | 0.410 |
Why?
|
| Female | 111 | 2022 | 66312 | 0.400 |
Why?
|
| Lipoproteins | 5 | 2013 | 178 | 0.390 |
Why?
|
| Genetic Linkage | 9 | 2015 | 452 | 0.390 |
Why?
|
| Lipoproteins, HDL | 5 | 2016 | 97 | 0.340 |
Why?
|
| Hypertriglyceridemia | 6 | 2016 | 102 | 0.340 |
Why?
|
| Flavonoids | 1 | 2010 | 78 | 0.340 |
Why?
|
| Aged | 48 | 2020 | 19406 | 0.340 |
Why?
|
| Epigenesis, Genetic | 4 | 2022 | 673 | 0.320 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2010 | 120 | 0.310 |
Why?
|
| Body Mass Index | 15 | 2015 | 1554 | 0.310 |
Why?
|
| Genotype | 22 | 2018 | 2548 | 0.310 |
Why?
|
| Humans | 123 | 2023 | 124311 | 0.310 |
Why?
|
| Diet, Sodium-Restricted | 7 | 2015 | 15 | 0.310 |
Why?
|
| Genome-Wide Association Study | 9 | 2020 | 1653 | 0.300 |
Why?
|
| Adrenal Glands | 2 | 2020 | 43 | 0.300 |
Why?
|
| Apolipoproteins B | 5 | 2010 | 131 | 0.290 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2017 | 49 | 0.280 |
Why?
|
| Heart | 2 | 2010 | 724 | 0.280 |
Why?
|
| Lipid Metabolism | 5 | 2016 | 357 | 0.280 |
Why?
|
| Postprandial Period | 6 | 2016 | 77 | 0.280 |
Why?
|
| Heart Ventricles | 8 | 2013 | 770 | 0.270 |
Why?
|
| Insulin | 8 | 2016 | 1211 | 0.270 |
Why?
|
| Epigenomics | 2 | 2018 | 161 | 0.260 |
Why?
|
| Inflammation | 5 | 2012 | 1414 | 0.250 |
Why?
|
| Interleukin-6 | 4 | 2012 | 414 | 0.250 |
Why?
|
| Histone Demethylases | 3 | 2022 | 38 | 0.240 |
Why?
|
| Hyperaldosteronism | 2 | 2020 | 16 | 0.240 |
Why?
|
| Multivariate Analysis | 11 | 2014 | 1416 | 0.240 |
Why?
|
| Cross-Sectional Studies | 12 | 2020 | 3412 | 0.230 |
Why?
|
| Hemodynamics | 6 | 2014 | 847 | 0.230 |
Why?
|
| Polymorphism, Genetic | 8 | 2011 | 807 | 0.230 |
Why?
|
| Genetic Loci | 2 | 2017 | 333 | 0.220 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2020 | 722 | 0.220 |
Why?
|
| DNA Methylation | 5 | 2018 | 997 | 0.220 |
Why?
|
| Chromosome Mapping | 7 | 2017 | 1082 | 0.220 |
Why?
|
| Odds Ratio | 6 | 2016 | 1247 | 0.220 |
Why?
|
| Dyslipidemias | 4 | 2020 | 228 | 0.220 |
Why?
|
| Population Surveillance | 1 | 2006 | 389 | 0.220 |
Why?
|
| Ventricular Function, Left | 8 | 2013 | 498 | 0.210 |
Why?
|
| Oxidoreductases, N-Demethylating | 2 | 2012 | 10 | 0.200 |
Why?
|
| Angiotensin II | 10 | 2020 | 162 | 0.200 |
Why?
|
| Genetic Variation | 7 | 2020 | 1492 | 0.200 |
Why?
|
| CD36 Antigens | 3 | 2017 | 37 | 0.200 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 3 | 2010 | 43 | 0.190 |
Why?
|
| Atherosclerosis | 5 | 2012 | 842 | 0.190 |
Why?
|
| Receptors, LDL | 2 | 1999 | 89 | 0.190 |
Why?
|
| Coronary Artery Disease | 5 | 2016 | 755 | 0.190 |
Why?
|
| Regression Analysis | 4 | 2012 | 773 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2020 | 1241 | 0.180 |
Why?
|
| Hypercholesterolemia | 3 | 2002 | 227 | 0.180 |
Why?
|
| Gene Frequency | 8 | 2016 | 718 | 0.180 |
Why?
|
| Salivary alpha-Amylases | 1 | 2020 | 2 | 0.180 |
Why?
|
| Risk Factors | 20 | 2020 | 10124 | 0.180 |
Why?
|
| Echocardiography, Doppler | 6 | 2013 | 171 | 0.170 |
Why?
|
| Aged, 80 and over | 13 | 2010 | 6450 | 0.170 |
Why?
|
| United States | 17 | 2020 | 10756 | 0.170 |
Why?
|
| Phenotype | 17 | 2015 | 4256 | 0.170 |
Why?
|
| Granzymes | 2 | 2010 | 37 | 0.170 |
Why?
|
| Family Health | 9 | 2011 | 259 | 0.170 |
Why?
|
| Dietary Carbohydrates | 1 | 2020 | 119 | 0.170 |
Why?
|
| CpG Islands | 3 | 2018 | 320 | 0.170 |
Why?
|
| Obesity | 7 | 2018 | 2254 | 0.170 |
Why?
|
| Angiotensinogen | 4 | 2011 | 21 | 0.170 |
Why?
|
| Particle Size | 4 | 2012 | 121 | 0.170 |
Why?
|
| Chemokine CCL2 | 3 | 2012 | 118 | 0.160 |
Why?
|
| Erythrocytes | 2 | 2012 | 207 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2013 | 3125 | 0.160 |
Why?
|
| Prevalence | 10 | 2020 | 2428 | 0.160 |
Why?
|
| Hypertension, Renal | 2 | 2012 | 37 | 0.160 |
Why?
|
| Apolipoprotein A-II | 1 | 2018 | 6 | 0.150 |
Why?
|
| Cohort Studies | 12 | 2018 | 4729 | 0.150 |
Why?
|
| Body Composition | 4 | 2005 | 524 | 0.150 |
Why?
|
| Endothelin-1 | 1 | 2017 | 39 | 0.150 |
Why?
|
| Cholesterol, VLDL | 4 | 2012 | 15 | 0.140 |
Why?
|
| Videotape Recording | 1 | 2017 | 57 | 0.140 |
Why?
|
| Lipoprotein(a) | 1 | 1998 | 116 | 0.140 |
Why?
|
| Fiber Optic Technology | 1 | 2017 | 46 | 0.140 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2007 | 133 | 0.140 |
Why?
|
| Fatty Acids | 2 | 2011 | 351 | 0.140 |
Why?
|
| Chylomicron Remnants | 1 | 2016 | 1 | 0.140 |
Why?
|
| Receptors, Mineralocorticoid | 2 | 2016 | 15 | 0.130 |
Why?
|
| Homeostasis | 5 | 2016 | 688 | 0.130 |
Why?
|
| Gastric Bypass | 1 | 2017 | 70 | 0.130 |
Why?
|
| Aortic Valve Insufficiency | 3 | 2003 | 142 | 0.130 |
Why?
|
| Lung Transplantation | 2 | 2010 | 318 | 0.130 |
Why?
|
| Ventricular Remodeling | 5 | 2004 | 177 | 0.130 |
Why?
|
| Laryngoscopy | 1 | 2017 | 150 | 0.130 |
Why?
|
| Resistin | 2 | 2016 | 36 | 0.120 |
Why?
|
| Renal Circulation | 3 | 2011 | 45 | 0.120 |
Why?
|
| Haplotypes | 3 | 2012 | 517 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2004 | 361 | 0.120 |
Why?
|
| Myocardial Contraction | 4 | 2004 | 262 | 0.120 |
Why?
|
| Waist Circumference | 1 | 2015 | 88 | 0.120 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 353 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2017 | 186 | 0.120 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2012 | 65 | 0.120 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 942 | 0.120 |
Why?
|
| Metabolomics | 1 | 2018 | 417 | 0.120 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2014 | 63 | 0.120 |
Why?
|
| Renal Plasma Flow | 1 | 2014 | 2 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2010 | 2082 | 0.110 |
Why?
|
| Intubation, Intratracheal | 1 | 2017 | 292 | 0.110 |
Why?
|
| Potassium | 4 | 2020 | 280 | 0.110 |
Why?
|
| Weight Loss | 1 | 2017 | 483 | 0.110 |
Why?
|
| Computers | 1 | 2013 | 67 | 0.110 |
Why?
|
| Systole | 6 | 2004 | 197 | 0.110 |
Why?
|
| Pedigree | 6 | 2013 | 1597 | 0.110 |
Why?
|
| Specialization | 1 | 2014 | 76 | 0.110 |
Why?
|
| Hand | 1 | 2014 | 101 | 0.110 |
Why?
|
| Stroke Volume | 5 | 2007 | 450 | 0.110 |
Why?
|
| Hyperlipoproteinemia Type II | 2 | 2005 | 84 | 0.100 |
Why?
|
| Television | 1 | 2013 | 71 | 0.100 |
Why?
|
| Linear Models | 5 | 2014 | 671 | 0.100 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2012 | 43 | 0.100 |
Why?
|
| Cardiovascular Diseases | 3 | 2014 | 1888 | 0.100 |
Why?
|
| Mineralocorticoids | 1 | 2012 | 8 | 0.100 |
Why?
|
| Electrocardiography | 5 | 2005 | 969 | 0.100 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 2535 | 0.100 |
Why?
|
| Diastole | 5 | 2004 | 170 | 0.100 |
Why?
|
| Sex Characteristics | 4 | 2017 | 318 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 1341 | 0.100 |
Why?
|
| Fasting | 3 | 2012 | 300 | 0.100 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2012 | 34 | 0.100 |
Why?
|
| Physician's Role | 1 | 2014 | 165 | 0.100 |
Why?
|
| Genetic Association Studies | 5 | 2016 | 766 | 0.100 |
Why?
|
| Echocardiography | 11 | 2006 | 1055 | 0.100 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2012 | 44 | 0.100 |
Why?
|
| Glucose | 1 | 2016 | 886 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2016 | 2823 | 0.100 |
Why?
|
| Surgery, Plastic | 1 | 2014 | 111 | 0.100 |
Why?
|
| Adipose Tissue | 4 | 2016 | 469 | 0.100 |
Why?
|
| Lod Score | 5 | 2015 | 120 | 0.100 |
Why?
|
| Lipoprotein Lipase | 1 | 2011 | 55 | 0.090 |
Why?
|
| Genome, Human | 3 | 2007 | 1272 | 0.090 |
Why?
|
| Kidney | 3 | 2014 | 1346 | 0.090 |
Why?
|
| Calcifediol | 1 | 2011 | 13 | 0.090 |
Why?
|
| Receptors, Calcitriol | 1 | 2011 | 71 | 0.090 |
Why?
|
| C-Reactive Protein | 4 | 2012 | 409 | 0.090 |
Why?
|
| Environment | 1 | 2011 | 145 | 0.090 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2011 | 136 | 0.090 |
Why?
|
| Alleles | 6 | 2012 | 1611 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2014 | 1522 | 0.090 |
Why?
|
| Age Factors | 5 | 2020 | 2812 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2012 | 759 | 0.080 |
Why?
|
| Young Adult | 7 | 2017 | 8955 | 0.080 |
Why?
|
| Aging | 3 | 2012 | 1197 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2012 | 384 | 0.080 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2009 | 40 | 0.080 |
Why?
|
| Logistic Models | 4 | 2016 | 1802 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2009 | 73 | 0.080 |
Why?
|
| Stress, Psychological | 2 | 2006 | 561 | 0.080 |
Why?
|
| Predictive Value of Tests | 7 | 2013 | 2128 | 0.080 |
Why?
|
| Students, Medical | 1 | 2014 | 356 | 0.080 |
Why?
|
| Immunosuppressive Agents | 2 | 2010 | 646 | 0.080 |
Why?
|
| Surveys and Questionnaires | 4 | 2014 | 3711 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1115 | 0.080 |
Why?
|
| Hydrocortisone | 3 | 2012 | 220 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 195 | 0.080 |
Why?
|
| Heart Function Tests | 2 | 2005 | 56 | 0.070 |
Why?
|
| Sex Factors | 6 | 2013 | 1268 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2007 | 59 | 0.070 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2007 | 31 | 0.070 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 44 | 0.070 |
Why?
|
| Follow-Up Studies | 4 | 2017 | 5096 | 0.070 |
Why?
|
| Vasculitis | 1 | 2007 | 49 | 0.070 |
Why?
|
| Uric Acid | 2 | 2006 | 93 | 0.070 |
Why?
|
| Mutation | 2 | 2011 | 5804 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 849 | 0.070 |
Why?
|
| Exercise | 1 | 2013 | 819 | 0.070 |
Why?
|
| Quantitative Trait Loci | 2 | 2006 | 284 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2007 | 92 | 0.070 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2007 | 87 | 0.070 |
Why?
|
| Iodide Peroxidase | 1 | 2007 | 8 | 0.070 |
Why?
|
| Postmenopause | 1 | 2007 | 125 | 0.070 |
Why?
|
| Cholesterol, LDL | 6 | 2012 | 560 | 0.070 |
Why?
|
| Blood Glucose | 5 | 2016 | 1131 | 0.070 |
Why?
|
| Linkage Disequilibrium | 3 | 2012 | 309 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2006 | 45 | 0.070 |
Why?
|
| Proteins | 1 | 2011 | 1042 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2022 | 3761 | 0.060 |
Why?
|
| Lovastatin | 1 | 2005 | 27 | 0.060 |
Why?
|
| Linolenic Acids | 1 | 2005 | 2 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2017 | 360 | 0.060 |
Why?
|
| alpha-Linolenic Acid | 1 | 2005 | 15 | 0.060 |
Why?
|
| Atrial Function, Left | 1 | 2005 | 27 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2006 | 159 | 0.060 |
Why?
|
| Linoleic Acid | 1 | 2005 | 14 | 0.060 |
Why?
|
| Microsatellite Repeats | 3 | 2001 | 219 | 0.060 |
Why?
|
| Heart Rate | 3 | 2005 | 591 | 0.060 |
Why?
|
| Myocardium | 2 | 2016 | 1001 | 0.060 |
Why?
|
| Leukocyte Count | 2 | 2006 | 247 | 0.060 |
Why?
|
| Incidence | 2 | 2017 | 3080 | 0.060 |
Why?
|
| Cytokines | 1 | 2010 | 1273 | 0.060 |
Why?
|
| Cluster Analysis | 3 | 2011 | 401 | 0.060 |
Why?
|
| Antihypertensive Agents | 3 | 2004 | 397 | 0.060 |
Why?
|
| Cardiac Output | 1 | 2005 | 170 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2012 | 1688 | 0.060 |
Why?
|
| Hyperuricemia | 1 | 2004 | 36 | 0.060 |
Why?
|
| Heart Conduction System | 1 | 2005 | 147 | 0.060 |
Why?
|
| Apolipoproteins E | 3 | 2012 | 190 | 0.060 |
Why?
|
| Thyroid Gland | 1 | 2004 | 113 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2014 | 1583 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2003 | 84 | 0.050 |
Why?
|
| Adolescent | 7 | 2017 | 19310 | 0.050 |
Why?
|
| Animals | 7 | 2022 | 34158 | 0.050 |
Why?
|
| Anticholesteremic Agents | 1 | 2005 | 233 | 0.050 |
Why?
|
| Sodium Chloride | 1 | 2023 | 95 | 0.050 |
Why?
|
| Tachycardia, Ventricular | 1 | 2005 | 197 | 0.050 |
Why?
|
| Nucleotides | 1 | 2023 | 93 | 0.050 |
Why?
|
| Dexfenfluramine | 1 | 2002 | 2 | 0.050 |
Why?
|
| Phentermine | 1 | 2002 | 7 | 0.050 |
Why?
|
| Fenfluramine | 1 | 2002 | 11 | 0.050 |
Why?
|
| Appetite Depressants | 1 | 2002 | 22 | 0.050 |
Why?
|
| Ultrasonography, Doppler | 1 | 2003 | 202 | 0.050 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 1999 | 70 | 0.050 |
Why?
|
| Mice | 5 | 2022 | 17757 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 1696 | 0.050 |
Why?
|
| Arousal | 1 | 2002 | 81 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2001 | 85 | 0.050 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2003 | 157 | 0.050 |
Why?
|
| Aorta | 1 | 2005 | 550 | 0.050 |
Why?
|
| Lisinopril | 1 | 2001 | 25 | 0.050 |
Why?
|
| Lysine | 1 | 2022 | 198 | 0.050 |
Why?
|
| Sinus of Valsalva | 1 | 2001 | 36 | 0.050 |
Why?
|
| Chromosome Segregation | 1 | 2001 | 62 | 0.050 |
Why?
|
| Aortic Valve Stenosis | 1 | 2005 | 339 | 0.040 |
Why?
|
| Norepinephrine | 2 | 2011 | 174 | 0.040 |
Why?
|
| Serum Albumin | 1 | 2001 | 109 | 0.040 |
Why?
|
| Pharmacogenomic Testing | 1 | 2020 | 37 | 0.040 |
Why?
|
| Pharmacogenomic Variants | 1 | 2020 | 35 | 0.040 |
Why?
|
| Vascular Resistance | 3 | 2007 | 189 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2010 | 151 | 0.040 |
Why?
|
| Body Weight | 3 | 2017 | 1009 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2001 | 210 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2020 | 260 | 0.040 |
Why?
|
| Utah | 2 | 2014 | 46 | 0.040 |
Why?
|
| Estrogens | 1 | 2022 | 518 | 0.040 |
Why?
|
| Feeding Behavior | 1 | 2005 | 713 | 0.040 |
Why?
|
| Epistasis, Genetic | 2 | 2012 | 91 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2012 | 670 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 3057 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2016 | 4533 | 0.040 |
Why?
|
| Zona Glomerulosa | 1 | 2017 | 3 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2003 | 778 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 509 | 0.040 |
Why?
|
| Fatty Acid Desaturases | 1 | 2017 | 8 | 0.040 |
Why?
|
| Sodium | 2 | 2010 | 294 | 0.040 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2017 | 9 | 0.040 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2017 | 37 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2018 | 253 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2010 | 803 | 0.040 |
Why?
|
| Apolipoproteins | 2 | 2005 | 68 | 0.040 |
Why?
|
| Age of Onset | 1 | 1998 | 582 | 0.030 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 15 | 0.030 |
Why?
|
| NADPH Oxidase 4 | 1 | 2016 | 15 | 0.030 |
Why?
|
| Remission Induction | 1 | 2017 | 301 | 0.030 |
Why?
|
| Aldehyde Reductase | 1 | 2016 | 17 | 0.030 |
Why?
|
| Spironolactone | 1 | 2016 | 18 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2011 | 106 | 0.030 |
Why?
|
| Multigene Family | 2 | 2007 | 298 | 0.030 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2016 | 27 | 0.030 |
Why?
|
| Diabetes Mellitus | 3 | 2015 | 852 | 0.030 |
Why?
|
| Sex Distribution | 3 | 2002 | 296 | 0.030 |
Why?
|
| Graft Rejection | 2 | 2010 | 590 | 0.030 |
Why?
|
| Laryngoscopes | 1 | 2017 | 69 | 0.030 |
Why?
|
| Energy Intake | 2 | 2011 | 491 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 1999 | 1763 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 426 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2007 | 139 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 609 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 376 | 0.030 |
Why?
|
| Apolipoprotein A-I | 2 | 2012 | 79 | 0.030 |
Why?
|
| Suicide | 1 | 2017 | 177 | 0.030 |
Why?
|
| Genetic Markers | 2 | 2009 | 606 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2016 | 173 | 0.030 |
Why?
|
| Organ Size | 2 | 2009 | 435 | 0.030 |
Why?
|
| p-Aminohippuric Acid | 1 | 2014 | 5 | 0.030 |
Why?
|
| Heredity | 1 | 2013 | 15 | 0.030 |
Why?
|
| Apolipoproteins A | 2 | 2011 | 46 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1289 | 0.030 |
Why?
|
| Physical Exertion | 1 | 2013 | 81 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 68 | 0.030 |
Why?
|
| Comorbidity | 3 | 2004 | 1509 | 0.030 |
Why?
|
| Orthopedics | 1 | 2014 | 66 | 0.030 |
Why?
|
| Cadherins | 1 | 2014 | 165 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 4353 | 0.030 |
Why?
|
| Exome | 1 | 2018 | 1042 | 0.030 |
Why?
|
| Trans Fatty Acids | 1 | 2012 | 10 | 0.030 |
Why?
|
| Potassium, Dietary | 1 | 2012 | 12 | 0.030 |
Why?
|
| Family | 1 | 2015 | 567 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 1107 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 157 | 0.020 |
Why?
|
| Lipoproteins, IDL | 1 | 2011 | 5 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2003 | 118 | 0.020 |
Why?
|
| Cytochrome P-450 CYP4A | 1 | 2011 | 2 | 0.020 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2011 | 15 | 0.020 |
Why?
|
| Data Collection | 1 | 2014 | 384 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2888 | 0.020 |
Why?
|
| Genotyping Techniques | 1 | 2012 | 103 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1570 | 0.020 |
Why?
|
| General Surgery | 1 | 2014 | 204 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 244 | 0.020 |
Why?
|
| Apolipoprotein A-V | 1 | 2011 | 20 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 484 | 0.020 |
Why?
|
| Registries | 1 | 2017 | 1411 | 0.020 |
Why?
|
| Azathioprine | 1 | 2010 | 54 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 534 | 0.020 |
Why?
|
| Child | 3 | 2017 | 24479 | 0.020 |
Why?
|
| Age Distribution | 2 | 2002 | 412 | 0.020 |
Why?
|
| Prednisolone | 1 | 2010 | 73 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2010 | 116 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 290 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2011 | 373 | 0.020 |
Why?
|
| Biomarkers | 3 | 2007 | 2974 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 393 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 532 | 0.020 |
Why?
|
| Tacrolimus | 1 | 2010 | 99 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2010 | 146 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 2010 | 170 | 0.020 |
Why?
|
| Epinephrine | 1 | 2010 | 176 | 0.020 |
Why?
|
| Vitamin D | 1 | 2011 | 160 | 0.020 |
Why?
|
| Hyperlipidemia, Familial Combined | 1 | 1989 | 2 | 0.020 |
Why?
|
| Prognosis | 2 | 2014 | 4548 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 796 | 0.020 |
Why?
|
| Liver | 1 | 2016 | 1754 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 235 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 3688 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2008 | 13 | 0.020 |
Why?
|
| Life Style | 1 | 2011 | 410 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2009 | 153 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2010 | 500 | 0.020 |
Why?
|
| Graft Survival | 1 | 2010 | 530 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2006 | 16223 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 2870 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 392 | 0.020 |
Why?
|
| Solubility | 1 | 2007 | 132 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2004 | 950 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 474 | 0.020 |
Why?
|
| Osteonectin | 1 | 2007 | 6 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 1 | 2007 | 80 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2007 | 97 | 0.020 |
Why?
|
| Ligands | 1 | 2008 | 534 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2007 | 123 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 1155 | 0.020 |
Why?
|
| DNA | 1 | 2012 | 1599 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2004 | 3261 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2007 | 100 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2007 | 137 | 0.020 |
Why?
|
| Time Factors | 2 | 2010 | 6259 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2006 | 55 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 548 | 0.020 |
Why?
|
| Hypokalemia | 1 | 2006 | 41 | 0.020 |
Why?
|
| Lipase | 1 | 2006 | 89 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2007 | 325 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1330 | 0.020 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2005 | 34 | 0.020 |
Why?
|
| Growth | 1 | 2005 | 106 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 424 | 0.020 |
Why?
|
| Estradiol | 1 | 2007 | 549 | 0.010 |
Why?
|
| Progesterone | 1 | 2007 | 631 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 312 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 2005 | 66 | 0.010 |
Why?
|
| Hormones | 1 | 2005 | 190 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2005 | 119 | 0.010 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 290 | 0.010 |
Why?
|
| Thyrotropin | 1 | 2004 | 60 | 0.010 |
Why?
|
| Overweight | 1 | 2007 | 359 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2005 | 180 | 0.010 |
Why?
|
| Posture | 1 | 2005 | 152 | 0.010 |
Why?
|
| Thyroxine | 1 | 2004 | 69 | 0.010 |
Why?
|
| Nutrition Assessment | 1 | 2005 | 136 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2003 | 112 | 0.010 |
Why?
|
| Skinfold Thickness | 1 | 2003 | 32 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2003 | 133 | 0.010 |
Why?
|
| Blood Proteins | 1 | 2003 | 116 | 0.010 |
Why?
|
| Heterozygote | 1 | 2005 | 677 | 0.010 |
Why?
|
| Siblings | 1 | 2004 | 196 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2004 | 451 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2008 | 815 | 0.010 |
Why?
|
| Heart Atria | 1 | 2005 | 318 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 1037 | 0.010 |
Why?
|
| Lung | 1 | 2010 | 1486 | 0.010 |
Why?
|
| Genome | 1 | 2005 | 475 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 12463 | 0.010 |
Why?
|
| Body Surface Area | 1 | 2002 | 31 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2001 | 50 | 0.010 |
Why?
|
| Fibrinogen | 1 | 2002 | 152 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2017 | 14052 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2001 | 103 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2002 | 267 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2001 | 94 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2002 | 228 | 0.010 |
Why?
|
| Immunoradiometric Assay | 1 | 2001 | 4 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 2001 | 22 | 0.010 |
Why?
|
| Supine Position | 1 | 2001 | 24 | 0.010 |
Why?
|
| Body Constitution | 1 | 2001 | 37 | 0.010 |
Why?
|
| Apolipoproteins C | 1 | 2000 | 11 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2004 | 870 | 0.010 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2001 | 51 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2002 | 196 | 0.010 |
Why?
|
| Apolipoprotein C-III | 1 | 2000 | 40 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2001 | 256 | 0.010 |
Why?
|
| Vasodilation | 1 | 2001 | 191 | 0.010 |
Why?
|
| Long QT Syndrome | 1 | 2001 | 85 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2011 | 6087 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2001 | 186 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 1014 | 0.010 |
Why?
|
| Mass Screening | 1 | 2006 | 786 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 1609 | 0.010 |
Why?
|
| Eating | 1 | 2000 | 374 | 0.010 |
Why?
|
| Genomics | 1 | 2006 | 1486 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 1012 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1997 | 183 | 0.010 |
Why?
|
| Stroke | 1 | 2005 | 972 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 709 | 0.010 |
Why?
|
| Heart Failure | 1 | 2005 | 2157 | 0.010 |
Why?
|